Avalere Health appoints new President of Medical to lead a tech-enabled future of medical affairs
February 6, 2024 | Executive appointment, Medical Communications, President of Medical, avalere health, medical affairs
Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.
London, February 6 — Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical. Baoutis will lead a team of 350+ scientific communicators into a future of medical communications fueled by an alchemy of science, creativity and technology.
Avalere Health has a deep heritage in this field, forming more than 20 years ago as a medical communications agency. Since then, it has evolved into a global commercialization partner, diversifying its offering to deliver from advisory to implementation across the entire product lifecycle.
The appointment of Baoutis is the latest of several high-profile executive leadership announcements made following Avalere Health’s rebrand on October 18, 2023, each reflecting Avalere Health’s evolution as a connected organization. The rebrand saw the company bring together 1,500+ team members across 19 locations in North America, Europe and Asia, uniting them under a single vision, organization and brand.
An established authority in healthcare communications, Baoutis is experienced in supporting large pharmaceutical clients and emerging biotech through her work at Omnicom, McCann Health, Real Chemistry and the Healthcare Communications Association. She is an expert in scientific engagement and has worked across a range of functions, including leadership roles in marketing and advertising. Her interdisciplinary approach and background make her well-positioned to collaborate across the business and develop advanced solutions to clients’ medical communications challenges.
“While modular content, personalized messaging, omnichannel and content value metrics were traditionally the realm of marketing, Medical teams are beginning to see the benefits of these approaches for building deeply engaging experiences for healthcare professionals,” said Amar Urhekar, Chief Operating Officer at Avalere Health. “Capitalizing on her cross-functional knowledge, Effie will ensure our experts infuse scientific information with the creativity and cutting-edge tools and platforms needed to support our clients in the technology-enabled future of medical communications.”
Under Baoutis’s leadership, the Medical team will support clients in remaining at the forefront of digital advancement, strategically leveraging the right tools, platforms and data to build cohesive learning experiences for customers. Her priorities include investing in new technology ecosystems to advance Avalere Health’s heritage in experience design and delivery and bringing together the company’s proprietary virtual congress platforms and publication planning tools. She will also work closely with Avalere Health’s in-house technologists and analysts to explore the multidimensional application of artificial intelligence in medical communications.
“I’m thrilled to join as the President of Medical at Avalere Health during a paradigm shift in medical communications,” said Baoutis. “The reputation of the team is unrivaled. We have the right combination of expertise to be a guiding light for our clients, helping them leverage the data, technologies and strategies to best meet their business goals and the needs of the stakeholders they serve.”
Established in 2001, Avalere Health is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Its 1,500+ experts combine their knowledge and expertise across its core disciplines — Consulting; Medical; Policy, Access, Value, and Evidence; Marketing; and Digital Experience Technology — to create the connections that make better health happen.
Avalere Health partners with its clients to navigate the complex and rapidly changing healthcare ecosystem. Together, its experts help clients connect patients with life-changing therapies, realizing the potential of strategies and solutions to accelerate innovation that improves lives. Visit www.avalerehealth.com and follow Avalere Health on LinkedIn and Instagram.
Contact information
Natasha Cowan
natasha.cowan@avalerehealth.com
Adi Nat
Company Details
Latest Content from Avalere Health
Avalere Health appoints new President of Medical to lead a tech-enabled future of medical affairs
Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.
Fishawack Health becomes Avalere Health, uncovering the potential in every product and the possibilities for every patient
As a single united organization, the company seamlessly connects science and creativity, technology and data, and ability and agility to ensure patients receive life-changing innovations faster.
Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities
As Chief Operating Officer, Amar will unite global teams to drive innovation, enhance client solutions, and accelerate growth.
Fishawack Health appoints Chief People Officer to spearhead integration of talent and culture across geographies
Fishawack Health welcomes Harriet Shurville to the team as Chief People Officer to spearhead integration efforts, champion diversity and inclusion, and cultivate an environment where interdisciplinary teams thrive.
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer
Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...
The challenges of reimbursement and innovative pricing for cell and gene therapies
Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...
Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes
Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...
Fishawack Health welcomes Mario Muredda as its new President of Marketing
Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.